(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide
C40H70N6O5 — CID 142857144
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide
(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide (PubChem CID 142857144) has the molecular formula C40H70N6O5 and a molecular weight of 715.04 g/mol. Its IUPAC name is (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide.
Molecular Properties
| Compound Name | (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide |
|---|---|
| PubChem CID | 142857144 |
| Molecular Formula | C40H70N6O5 |
| Molecular Weight | 715.04 g/mol |
| Exact Mass | 714.54 |
| IUPAC Name | (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-[2-[4-(methylamino)phenyl]ethylamino]-3-oxopropyl]pyrrolidin-1-yl]-3,5-dimethyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide |
| SMILES | CC[C@H](C)[C@@H]([C@H](C)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccc(NC)cc1)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C |
| InChI | InChI=1S/C40H70N6O5/c1-14-27(6)36(45(12)40(50)34(25(2)3)43-39(49)35(26(4)5)44(10)11)28(7)24-33(47)46-23-15-16-32(46)37(51-13)29(8)38(48)42-22-21-30-17-19-31(41-9)20-18-30/h17-20,25-29,32,34-37,41H,14-16,21-24H2,1-13H3,(H,42,48)(H,43,49)/t27-,28+,29+,32-,34-,35-,36-,37+/m0/s1 |
| InChIKey | SRXLRNKMBPXOPA-DMQRTGIMSA-N |
| XLogP | 4.66 |
| TPSA | 123.32 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 715.04 |
| LogP ≤ 5 | 4.66 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142857144 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.